First Successful Use of Penicillin

The first successful use of penicillin happened on February 12, 1941, when Albert Alexander, a 43-year-old police constable, received a 200-unit intravenous dose. Within just 24 hours, his temperature dropped and his infected wounds showed less discharge. The team even extracted penicillin from his urine to keep the treatment going. Animal tests had already proven it wasn't toxic, and clinical trials on 170 patients confirmed zero side effects. There's much more to this remarkable story.

Key Takeaways

• Albert Alexander, a 43-year-old constable, became the first human to receive penicillin on 12 February 1941.
• Within 24 hours, Alexander's temperature dropped and his suppurating wounds showed significantly reduced discharge.
• The team extracted penicillin from Alexander's own urine to replenish their dwindling supply during treatment.
• Penicillin targeted multiple infection sites simultaneously, distinguishing it from all previous available treatments.
• Alexander's case directly shaped the successful recoveries of four seriously ill patients who followed him.

The Oxford Policeman Who First Received Penicillin

Albert Alexander, a 43-year-old Reserve Constable in Oxford County's police force, became the first human to receive penicillin on 12 February 1941. His ordeal began with a simple rose scratch in early autumn 1940 that spiraled into life-threatening abscesses ravaging his eyes, face, and lungs.

You'd recognize the reserve constable's courageous battle as one born from devastating circumstance rather than choice. Florey's team selected Alexander precisely because his condition was terminal, making him an ideal candidate for their experimental treatment despite unknown dosages and potential side effects. His infection had been identified as a dangerous combination of Staphylococcus and Streptococcus, two bacterial strains that were notoriously difficult to treat before the advent of antibiotics.

Alexander's selfless medical contribution, though ending in tragedy when penicillin supplies ran out before completing his treatment, proved the antibiotic's remarkable potential and directly shaped the successful recoveries of four seriously ill patients who followed him. The groundbreaking work carried out at the Dunn School was largely made possible by Norman Heatley, whose pivotal contributions to the development of penicillin earned him recognition as the forgotten man behind one of medicine's greatest achievements.

What Happened Within the First 24 Hours of Treatment?

When Florey's team administered that first 200-unit intravenous dose to Albert Alexander on 12 February 1941, the results were nothing short of astonishing. Within just 24 hours, you could see a dramatic treatment response across Alexander's entire body.

His temperature dropped, his suppurating wounds showed considerably reduced discharge, and his serious abscesses began clearing. Alexander's recovery trajectory looked genuinely promising, considering how grave his condition had been before treatment.

The Oxford team then continued with 100-unit follow-up doses every three hours, sustaining the momentum that initial dose had created. What made this treatment response so remarkable wasn't just the speed — it was the breadth. Multiple infection sites throughout his body were simultaneously responding to a drug that had never before been tested on a human patient. The groundwork for this moment had been laid when Oxford team's results were published in The Lancet in 1940, validating the case for human trials.

As penicillin was rapidly used up during Alexander's treatment, the team resorted to extracting it from urine to replenish their dwindling supply and continue the course of treatment.

How Animal Tests Proved Penicillin Actually Worked

Those dramatic results in February 1941 didn't emerge from nowhere — they were built on nearly a year of rigorous animal testing that transformed penicillin from a curious laboratory observation into a credible medical treatment.

Key safety milestones came early, with rats, mice, rabbits, and cats showing no toxic reactions during initial trials in March 1940. Then on May 25, 1940, Florey's team injected eight mice with deadly Streptococcus — four went untreated, and all four died by early morning. The treated mice survived. Florey called it "a miracle."

The scientific significance of findings only deepened as experiments scaled up, eventually involving fifty mice and confirming penicillin's effectiveness against streptococci, staphylococci, and gas gangrene bacteria — giving researchers the confidence to finally test it on humans. This progress was made possible largely through the work of Norman Heatley, whose successful purification efforts enabled penicillin to be produced in quantities sufficient for meaningful experimentation.

Chain was instrumental in extracting the antibacterial material from Penicillium notatum, isolating a substance that proved non-toxic to animals while retaining its powerful antibacterial properties — a critical finding that gave the team confidence to pursue further trials.

Why Penicillin Was Safer Than Any Antibiotic Before It

What made penicillin genuinely revolutionary wasn't just that it worked — it was that it worked without turning the body's own systems against itself. Earlier treatments like sulfonamides got destroyed by pus, making them useless in infected wounds. Penicillin didn't have that problem.

The antibiotic's selective toxicity meant it targeted bacterial cells while leaving your tissue cells and white blood cells completely unharmed. That distinction mattered enormously. Your immune system could keep functioning normally while the drug did its work, reinforcing your defenses rather than undermining them.

This robust safety profile held up across extensive animal testing and clinical trials involving 170 patients between 1941 and 1942 — with zero toxic side effects reported. No antibiotic before it had managed that combination of effectiveness and human safety. After its widespread introduction in post-war Italy, mortality rates for penicillin-sensitive causes like pneumonia and syphilis declined by 58%.

Despite its safety advantages, penicillin is today the most frequently reported drug allergy, though confirmed hypersensitivity has significantly declined since the 1960s, partly due to cleaner penicillin products and a shift toward lower dose oral use instead of parenteral administration.

Why Penicillin Made Every Existing Antibiotic Look Weak

Penicillin's safety advantage was impressive, but its real dominance came from raw killing power. Its novel therapeutic mechanisms didn't just slow bacteria—they destroyed them. You'd see unexpected clinical impacts that older drugs simply couldn't produce.

Sulfonamides often failed in deep-seated infections, but penicillin pushed through where they couldn't. It covered gram-positive cocci, anaerobes, and gram-negative cocci simultaneously—the exact pathogens causing the deadliest infections of the era.

Here's what made it untouchable early on:

• It lysed bacterial cells rather than merely slowing their growth
• It hit major pathogens at remarkably low concentrations
• Early resistance was rare, making failures almost nonexistent

Every existing treatment looked weak because penicillin didn't compromise—it eliminated. FDA approved in 1943, it became the foundational benchmark against which every subsequent antibiotic would be measured.

Studies on odontogenic abscesses have reinforced this legacy, showing that penicillin's clinical efficacy persists even when its in vitro sensitivity rates appear modest, largely because dominant aerobe and anaerobe strains retain meaningful susceptibility to it.

The Bizarre Containers Used to Produce Early Penicillin

When production demanded more volume, the team turned to dairy equipment modifications, repurposing metal milk churns originally designed for sanitary liquid transport. These improvised growth vessels bridged the gap between kitchen-scale containers and true industrial fermenters.

Eventually, bedpan geometry proved so effective that manufacturers produced custom ceramic trays modeled directly on it. What looked like a chaotic jumble of household objects was actually a functioning, wartime penicillin factory operating under severe resource constraints. American drug companies played a pivotal role in scaling up production, ensuring sufficient penicillin was available by D-Day in 1944.

How Penicillin Went From Priceless to $0.55 a Dose

The story of penicillin's price collapse is one of the most dramatic in medical history. Mass production techniques and price reduction strategies transformed an unaffordable miracle drug into something ordinary people could actually access.

Consider this pricing timeline:

• 1940: Penicillin was fundamentally priceless due to microscopic yields
• July 1943: One dose cost $20, still expensive but obtainable
• 1946: That same dose dropped to just $0.55

You can credit deep-tank fermentation and wartime government pressure for driving this transformation. The War Production Board pushed pharmaceutical companies hard, and it worked. Between 1943 and 1945, the price per million units fell from $200 to $6. By March 1945, penicillin reached public distribution, finally making this life-saving antibiotic accessible to everyday Americans. Clinical trials in 1943 confirmed penicillin was the most effective antibacterial agent available, providing the scientific validation that justified the massive push to scale up production. Early production yielded only 1.2 micrograms per milliliter, meaning the initial microscopic yields made penicillin completely unaffordable for ordinary patients before these breakthroughs transformed the industry.

The Publication That Shocked the Medical World in 1940

Few scientific publications have landed with as much force as the August 1940 paper in The Lancet, where Howard Florey and Ernst Chain detailed penicillin's production, purification, and experimental results.

You have to ponder the context: Fleming's minimal recognition following his 1929 discovery had left penicillin largely dormant for over a decade, and experts' skepticism ran deep. Professor Harold Raistrick had even declared therapeutic production "almost impossible."

Yet Florey's 1940 mouse experiments proved otherwise, demonstrating penicillin's potency against Streptococcus pyogenes, Staphylococcus aureus, and Clostridium septique. Chain described the results as "a miracle," and the medical world couldn't ignore the findings this time.

That single publication transformed penicillin from a forgotten curiosity into medicine's most promising therapeutic breakthrough. Florey and Chain had first uncovered Fleming's research in 1937, assembling a dedicated team of scientists to work solely on bringing the Penicillin Project to life.

Penicillin's Role in Treating Soldiers During World War II

World War II created the perfect crucible for penicillin's shift from experimental compound to life-saving battlefield medicine. Mass scale production became urgent, with Pfizer alone preparing 23 million doses for D-Day.

Prophylactic applications transformed wound care entirely — soldiers who'd previously faced devastating infections now recovered within weeks.

• Amputation rates dropped from 8% using standard methods to just 3% with penicillin treatment
• Gas gangrene cases among Allied troops hit only 1.5 per thousand, compared to 20–30 per thousand among German prisoners using sulfa drugs
• Between D-Day and VE-Day, medics treated over 100,000 wounded with penicillin, reducing infection severity in 93.1% of cases

Penicillin didn't just treat wounds — it fundamentally changed who survived them. Over 150,000 Allied troops landed on 5 Normandy beachheads on 6 June 1944, and penicillin is estimated to have reduced Allied lives lost that day by 12–15%.

Before penicillin, soldiers relied on sulfa drugs, which were used so frequently that resistant pathogens developed, undermining their effectiveness and making a superior alternative essential.

How That First Treatment Sparked the Modern Antibiotic Era

Before penicillin reached those D-Day battlefields, it first had to prove itself in a single, desperate experiment — one that would either validate decades of laboratory work or relegate Alexander Fleming's mold discovery to scientific footnote.

On February 12, 1941, Oxford policeman Albert Alexander received 200 units intravenously. Within 24 hours, his massive abscesses began retreating. Doctors had discovered the life saving potential of this compound firsthand.

Then the critical drug shortage struck. Supplies exhausted after five days, forcing researchers to extract penicillin from Alexander's own urine. He relapsed and died March 15, 1941.

Yet his case galvanized governments on both sides of the Atlantic. That single trial transformed penicillin from laboratory curiosity into an urgent manufacturing priority, ultimately launching the modern antibiotic era. Fleming, Chain, and Florey were awarded the Nobel Prize in 1945 for their groundbreaking contributions to the discovery and development of penicillin.